Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 16/20 | 0.47 |
| ▸ | ADAM17 | P78536 | 9/20 | 0.47 |
| ▸ | MMP13 | P45452 | 2/20 | 0.46 |
| ▸ | MMP3 | P08254 | 3/20 | 0.45 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5759516 | 0.98 | MMP1 (0.49) | MMP1ADAM17MMP13MMP3MMP7 | |
| Hydroxyamine SCHEMBL7156722 | 0.93 | MMP1 (0.54) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL7155386 | 0.92 | MMP1 (0.46) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL7450392 | 0.91 | MMP1 (0.57) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL5760537 | 0.91 | MMP1 (0.57) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL7155381 | 0.88 | MMP1 (0.47) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL27573428 | 0.86 | MMP1 (0.49) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL5759833 | 0.85 | MMP1 (0.48) | MMP1ADAM17MMP13MMP3MMP7 | |
| SCHEMBL7156717 | 0.84 | MMP1 (0.53) | MMP1ADAM17MMP13MMP3MMP9 | |
| SCHEMBL5758094 | 0.83 | MMP1 (0.61) | MMP1ADAM17MMP13MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030008901-A1 | Hydroxy pipecolate hydroxamic acid derivatives | MCCLURE KIM F (US) | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008901-A1 | Hydroxy pipecolate hydroxamic acid derivatives | MMP1, MMP10, MMP3 | MMP1 1/4885ADAM17 221/4885MMP13 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.